Healthcare and Pharmaceuticals
Global Animal Antimicrobials and Antibiotics Market was valued at USD XX billion in the year 2017. Global Animal Antimicrobials and Antibiotics market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023.
In the Global Animal Antimicrobials and Antibiotics Market, by region, North America region holds the highest market share in 2017 and the Asia Pacific is also market is considered as the fastest growing market in the forecasted period owing to their market demands. At the country level, U.S, China, and India is projected to grow strongly in the coming years.
Rising Demand for Animal-Derived Food Products
Changing government regulations and norms.
Lack of New Antibiotics
Investment opportunity in emerging markets
Strict regulatory framework
The segmentation is done on the basis of resin type, of product, mode of delivery, animal type, and region. On the basis of the product, the market is segmented into tetracyclines, penicillins, macrolides, aminoglycosides, sulfonamides, fluoroquinolones, lincosamides, cephalosporins, and other antimicrobials and antibiotics. The tetracyclines accounted for the largest share of the animal antibiotics and antimicrobials market in 2017.
Zoetis, Inc. (U.S.), Merck & Co., Inc. (U.S.), Eli Lilly and Company (U.S.), Bayer AG (Germany), Virbac (France), Boehringer Ingelheim GmbH (Germany), Sanofi (France), Ceva Sante Animale (France), Vetoquinol S.A. (France), and Dechra Pharmaceuticals PLC (U.K.) are some of the key players in the Global Animal Antimicrobials and Antibiotics market.
Key Benefits for Stakeholders
Animal Pharmaceutical Manufacturers
Animal Healthcare Product Distributors
Animal Health Research and Development (R&D) Companies
Market Research and Consulting Firms
Other Antimicrobials and Antibiotics
By Mode of Delivery
Other modes of delivery
By Animal Type
Sheep and Goats
Other Food-Producing Animals
Other Companion Animals
Key Market Players
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck & Co., Inc.
Ceva Sante Animale
Dechra Pharmaceuticals PLC
(A brief overview of 10 companies is also provided)
Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –
Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
22.214.171.124. Key Data from Secondary Research
2.1.2. Primary Research
126.96.36.199. Key Data from Primary Research
188.8.131.52. Breakdowns of Primary Interviews
2.2. Market Size Estimation
2.2.1. Bottom-Up Approach
2.2.2. Top-Down Approach
2.2.3. Annual Revenue Process
2.3. Data Triangulation
2.4. Research Assumptions
3. Executive Summary
4. Market Overview
4.7. Supply Chain/Value Chain Analysis
4.8. Patent & Standards
5. Industry Trends
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Buyers
5.2.4. Bargaining Power of Suppliers
5.2.5. Intensity of Competitive Rivalry
6. Animal Antimicrobials and Antibiotics Market, By Product
6.9 Other Antimicrobials and Antibiotics
7. Animal Antimicrobials and Antibiotics Market, By Mode of Delivery
7.2 Oral Powders
7.3 Oral Solutions
7.5 Other modes of delivery
8. Animal Antimicrobials and Antibiotics Market, By Animal Type
8.1 Food-Producing Animals
8.1.4 Sheep and Goats
8.1.5 Other Food-Producing Animals
8.2 Companion Animals
8.2.4 Other Companion Animals
9. Geographical Analysis
9.2. North America
9.4. Asia Pacific
9.4.1. South Korea
9.5.1. Latin America
9.5.2. Middle East and Africa
10. Company Profiles
(Business Overview, Financial Overview, Product write Up, Recent Developments)
10.1 Zoetis, Inc.
10.2 Boehringer Ingelheim GmbH
10.3 Eli Lilly and Company
10.4 Merck & Co., Inc.
10.5 Bayer AG
10.7 Ceva Sante Animale
10.9 Vetoquinol S.A.
10.10 Dechra Pharmaceuticals PLC
(A brief overview of 10 companies is also provided.)
11. Competitive Analysis
11.2. Market Positioning of Key Players
11.3 Competitive Strategies Adopted by Leading Players
11.3.1. Investments & Expansions
11.3.2. New Product Launches
11.3.3. Mergers & Acquisitions
11.3.4. Agreements, Joint Ventures, and Partnerships
12.2. Available Customizations
12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)
*The list of tables and figures will be provided in the sample report.
No Content Available.